First-in-Man Study of Simvastatin-Eluting Stent in De Novo Coronary Lesions

Abstract

In this sample of patients with de novo coronary lesions, the use of a SimvES was not related to major adverse cardiac events, but it was associated with a higher level of neointimal proliferation than expected.